New investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are demonstrating significant effects in addressing weight gain and diabetes second-type diabetes. Initial data suggest a distinct https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/